# Gregory P. Hess

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gregory-p-hess/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,260 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 26 |
| i10-index | 53 |
| Last Known Institution | Patient Advocate Foundation |
| OpenAlex ID | https://openalex.org/A5033435340 |
| ORCID iD | 0000-0001-8942-6865 |
| Works | 134 |

## Researcher papers

- [Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/clinical-course-of-patients-with-worsening-heart-failure-with-reduced-ejection/)
- [Prevention and Treatment of Overuse Tendon Injuries](https://scholariq.org/papers/prevention-and-treatment-of-overuse-tendon-injuries/)
- [Prevalence of narcolepsy and other sleep disorders and frequency of diagnostic tests from 2013–2016 in insured patients actively seeking care](https://scholariq.org/papers/prevalence-of-narcolepsy-and-other-sleep-disorders-and-frequency-of-diagnostic/)
- [Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice](https://scholariq.org/papers/systemic-therapy-for-metastatic-colorectal-cancer-patterns-of-chemotherapy-and/)
- [Survival implications of opioid use before and after liver transplantation](https://scholariq.org/papers/survival-implications-of-opioid-use-before-and-after-liver-transplantation/)
- [Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings.](https://scholariq.org/papers/pharmacogenetic-guided-psychiatric-intervention-associated-with-increased/)
- [IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders](https://scholariq.org/papers/iv-immunoglobulin-is-associated-with-a-reduced-risk-of-alzheimer-disease-and/)
- [Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients](https://scholariq.org/papers/sirolimus-use-and-cancer-incidence-among-us-kidney-transplant-recipients/)
- [Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy](https://scholariq.org/papers/proprotein-convertase-subtilisin-kexin-type-9-inhibitor-therapy/)
- [Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes](https://scholariq.org/papers/prescription-opioid-use-before-and-after-kidney-transplant-implications-for/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Opioid Use Disorder Treatment](https://scholariq.org/topics/opioid-use-disorder-treatment/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Patient Advocate Foundation](https://scholariq.org/institutions/patient-advocate-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.